• We are a fully integrated vaccine company with two travel vaccines on the market.

  • Dedicated to innovation in vaccine research and development.

  • Valneva’s lead clinical late stage programs address hospital and healthcare associated infections.

  • Valneva covers the full value chain from research to market.

 

Welcome to Valneva

A leading pure play vaccine company.

2015 Annual Business Report

— July 12, 2016

European Investment Bank Grants Valneva a €25 Million Loan to Fund R&D Activities
Read more

— Stock information

— Financial Calendar


June 30, 2016
Annual General Meeting, Lyon

August 31, 2016
H1 2016 results

See all dates

AKTUELLES

News in German


 

VALNEVA
LIBRARY

Images, presentations and videos

JAPANESE
ENCEPHALITIS
AND
CHOLERA




learn more
play video Valneva's CEO Thomas Lingelbach
comments on Group Strategy

– Upcoming conferences and fairs



Rodman & Renshaw 18th Annual Global Investment Conference
New York, US
September 11-13, 2016










map

A leading pure play vaccine company with international footprint.

Locations
Please update your browser...